Key facts
- This page summarizes Mai-Britt Zocca's Form 4 filing for IO Biotech, Inc. (IOBT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2024, 18:56.
Mai-Britt Zocca - 23 Dec 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- IOBT
- Reported as of
- 23 Dec 2024
- Net transaction value
- +$10,120
- SEC form
- 4
- Accepted by SEC
- 23 Dec 2024, 18:56:14 UTC
- Prior SEC filing
- 18 Mar 2024
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mai-Britt Zocca filed Form 4 for IO Biotech, Inc. (IOBT) on 23 Dec 2024.
Change
- Previous filing in this sequence was filed on 18 Mar 2024.
- Current net transaction value: +$10,120.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IOBT
transaction
Common Stock
Purchase
- Transaction value
- $10,120
- Shares
- +12,500
- Change %
- +33%
- Price
- $0.8096
- Shares after
- 49,891
- Date
- 23 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
IOBT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 26,580
- Date
- 23 Dec 2024
- Ownership
- Zocca Consulting ApS
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations.
Footnote F2
The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.